午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ChemicalBook
Chinese English Germany Korean

TargetMol Chemicals Inc. 企業(yè)の連絡(luò)先情報

名前:TargetMol Chemicals Inc.
電話番號:-
電子メール:marketing@targetmol.cn
國籍:China
ウェブサイト:https://www.targetmol.cn/
商品の合計數(shù):21356

製品カタログ

STAT6-IN-3371919-80-1C32H35IN3O7P
Enpp-1-IN-172289736-54-3C18H24N4O2
Mcl-1 inhibitor 132445466-06-6
MEK-IN-6 hydrate2845153-35-5
FKBP51F67V-selective antagonist Ligand21680228-76-5C43H56N2O10
DSO-5a2195411-63-1C23H24N2O7
FD20562685870-87-3C23H17ClN6O2S
Lp-PLA2-IN-151865796-11-7C22H17F5N4O3
SLMP53-21826116-38-4C26H22N2O2
BET-IN-152408994-22-7C21H18F2N4O3S
Antileishmanial agent-162934738-41-5C27H37N5O4
IRE1α kinase-IN-91338933-30-4C24H24N2O6
SHP2-IN-142673400-91-2C22H20Cl2N8O
UPCDC307662152623-68-0C30H32F2N6O3S
MmpL3-IN-22944458-65-3C27H30N2
RIP1 kinase inhibitor 42919836-00-1
PCSK9-IN-172455424-72-1C16H19N5OS
BBDDL20592691174-27-1C27H36N4O4S
JAK-IN-302891469-99-9C19H26N8S
Antitubercular agent-391357796-08-7C26H30N4O2
ATR-IN-242370889-43-1C23H26N6O2
TLR7/8 agonist 82649170-16-9C24H30N6O
DRI-C210412101765-78-8C30H21N3O7S
ROCK-IN-62489328-74-5C19H19N5O8S
Antileishmanial agent-172934738-40-4C27H37N5O5
THRβ receptor agonist-12403721-00-4
P2X3 antagonist 382545974-71-6C22H25F3N6O3
FGFR-IN-112658488-68-5C28H29ClN4O4
Antiproliferative agent-302713553-88-7C24H26N4O4
PI3Kγ inhibitor 72575863-25-9C31H25N9O2
RIP1 kinase inhibitor 62428401-62-9C19H18F2N2O3
CXCR4-IN-12304750-48-7C23H32N6
PIKfyve-IN-22245319-25-7C22H22N8O
PHD2-IN-12768219-28-7C21H23ClN4O5
ALK/EGFR-IN-12730430-08-5C27H34ClN7O3S
URAT1&XO inhibitor 12669726-78-5C20H13N5O3S
TNF-α-IN-102247720-56-3C17H14O4
MEK-IN-62845151-86-0C18H20FN3O4S
SOS1-IN-162930763-85-0C30H31F3N4O3
ETAP2575731-47-2C18H17N3O
Antiproliferative agent-342910858-34-1C27H27N7O5
DGKζ-IN-12660218-70-0C27H25F3N6O2S
Mosnodenvir2890688-86-3C26H22ClF3N2O6S
RET-IN-232479961-46-9C28H28FN11
PB1312924425-63-6C16H16FN3O2
Lp-PLA2-IN-132756855-62-4C22H17F5N4O4
JAK-IN-282445500-22-9C20H18ClN7O
Tubulin polymerization-IN-422640220-51-3C22H21NO5
BChE-IN-172425632-57-9C23H23BrN2O4S2
HPK1 antagonist-12628489-56-3C28H29FN6O2
CDK7-IN-222173190-60-6C22H25F3N6
MDM2/XIAP-IN-22761969-85-9C29H32N2O4S
Antileishmanial agent-152934738-38-0C28H39N5O4
IRE1α kinase-IN-81338933-29-1
Antifungal agent 592422019-96-1
Antitumor agent-1012848632-52-8C26H38N6O3
PAD4-IN-22642327-52-2C20H23BClN7O6
MAT2A-IN-12631897-75-1C20H17NO3
IRAK4-IN-282952532-92-0C27H31N9O3
ALK2-IN-52414149-20-3C24H32N8O2
Anticancer agent 1472241283-11-2C32H40BrN3O2
AMPK activator 112948304-00-3C25H20N4O2
K-80001242800-40-4C20H17FO2
RIP1 kinase inhibitor 72428401-23-2C20H20FN3O
Lp-PLA2-IN-122637485-14-2
PROTAC α-synuclein degrader 52781922-42-5C39H41N7O10
Antiproliferative agent-322925814-05-5C19H15NO2
KAT modulator-11314006-43-3C20H36O2
Z10786019261493256-85-1C14H19FN2O
AMPA receptor modulator-42917551-59-6C11H12ClFN2O2S
IPG72362756350-91-9C23H31N3O3S
Lp-PLA2-IN-161865780-73-9C22H17F5N4O3
URAT1&XO inhibitor 21239488-96-0C14H12BrNO3
HIV-1 inhibitor-562952530-45-7C22H14ClN7O2S
Tegeprotafib2407610-46-0C13H11FN2O5S
Bivamelagon hydrochloride2641595-55-1C35H54Cl2N4O4
SARS-CoV-2-IN-571265624-68-7C23H37N3O
BDM915142892824-90-5
SOS1/KRAS-IN-12836330-34-6C24H26F3N5O
Lp-PLA2-IN-142756855-66-8
Antibacterial agent 1412930013-56-0C23H27ClN2O3
SORT-PGRN interaction inhibitor 32691846-87-2C15H19Cl2NO3
SUCNR1-IN-12711753-52-3C26H22ClF3N2O4
DRI-C254412101765-83-5C31H21N3O6
TLR7/8 agonist 92649170-17-0C20H26N6O
SSI-41875084-68-6C19H21ClN4O3
Tau protein aggregation-IN-1916179-45-8C17H11BrN2O2
Bivamelagon2641595-54-0C35H53ClN4O4
PCSK9-IN-162455424-51-6C16H20N6O2S3
TLR8 agonist 62616605-55-9C19H29N7O2
VMAT2-IN-2 tosylate2608770-12-1C27H36F3NO6S
Bromodomain inhibitor-12 (edisylate)2010124-27-1C28H38N4O5.C2H6O6S2
S-Gem2169925-98-6C13H15F2N3O6S2
RIP1 kinase inhibitor 52428422-17-5C13H17F2NO2
TRK-IN-232924344-29-4C20H17FN4O2
Bromodomain inhibitor-122010124-06-6
A1/A3 AR antagonist 32665804-57-7C22H19N5O3
Protein kinase inhibitor 52278204-94-5C29H31F2N7O
HDAC ligand-12′-アミノホルムアニリド34840-28-3C7H8N2O
Copyright 2017 ? ChemicalBook. All rights reserved